SK

Seema Kanugo

Active Director Director DIN 07204336
DIN 07204336 First appointment Jul 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Seema Kanugo

Data last updated:

Seema Kanugo is a Director at Lesante Pharma Private Limited (since 2015). The company operates in Chemicals. Lesante Pharma Private Limited reported revenue of ₹67.3 Lakh (FY 2025).

DIN 07204336
Primary Designation Director
Industry Chemicals
First Appointment 01 Jul 2015
Oldest Company Age 11 yrs
Largest company Lesante Pharma Private Limited · ₹67.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lesante Pharma Private Limited U24100MP2015PTC034402
Director01 Jul 20152015₹67.3 Lakh (FY 2025)Active

Board colleagues of Seema Kanugo

NameDINCompanyDesignation
Harish Kanugo07204331Lesante Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lesante Pharma Private Limited
Premium access

Shareholding and investment profile for Seema Kanugo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Kanugo

Seema Kanugo currently holds 1 directorship: Lesante Pharma Private Limited (Director, since 01 Jul 2015, revenue ₹67.3 Lakh (FY 2025)).

Seema Kanugo was first appointed on 01 Jul 2015 as Director at Lesante Pharma Private Limited.

The current boards of Seema Kanugo's companies include Harish Kanugo (Lesante Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available